Longevity Factor Klotho and Resistance to Cognitive Deficits in Individuals with Parkinson’s Disease and in an α-Synuclein Mouse Model

, linked to higher circulating klotho levels, associated with better executive cognition in individuals with PD across two independent cohorts. To test causality and explore mechanisms, we turned to mouse models. Transgenic elevation of klotho in a mouse model increased lifespan, improved synaptic and cognitive, but not motor, functions in mice, and decreased steady-state α-synuclein (α-syn) levels in the brains of male mice expressing wild-type human α-syn. Complementary in vitro studies showed that klotho rescued α-syn-induced deficits in NMDAR-dependent signaling through GluN2B and augmented α-syn microglial-related uptake, suggesting a potential mechanism by which klotho counters PD-related toxicity. Together, these findings indicate that klotho can counteract cognitive deficits related to PD, possibly by modulating α-syn levels, and these findings may be relevant to new therapeutic pathways for PD.

Authors

Institutions

Publication Details

Journal
Journal of Neuroscience
Published
2026-03-31
DOI
https://doi.org/10.1523/jneurosci.1904-25.2026
Primary Topic
Parathyroid Disorders and Treatments
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Longevity Factor Klotho and Resistance to Cognitive Deficits in Individuals with Parkinson’s Disease and in an α-Synuclein Mouse Model

Cana Park, Lauren Broestl, Sylvain Lesné, Alexandre Bétourné et al.
Journal of Neuroscience
Parathyroid Disorders and Treatments
article

Longevity Factor Klotho and Resistance to Cognitive Deficits in Individuals with Parkinson’s Disease and in an α-Synuclein Mouse Model

Cana Park, Lauren Broestl, Sylvain Lesné, Alexandre Bétourné, Claire Huguenard, Dena B. Dubal, Jill L. Ostrem, Samira Abdulai-Saiku, Shweta Gupta, Arturo J. Moreno, Rohan Sehgal, Luke W. Bonham, Jennifer S. Yokoyama, Jonathan Y. Lin, Nijee Luthra, Dan Wang
article en

Abstract

, linked to higher circulating klotho levels, associated with better executive cognition in individuals with PD across two independent cohorts. To test causality and explore mechanisms, we turned to mouse models. Transgenic elevation of klotho in a mouse model increased lifespan, improved synaptic and cognitive, but not motor, functions in mice, and decreased steady-state α-synuclein (α-syn) levels in the brains of male mice expressing wild-type human α-syn. Complementary in vitro studies showed that klotho rescued α-syn-induced deficits in NMDAR-dependent signaling through GluN2B and augmented α-syn microglial-related uptake, suggesting a potential mechanism by which klotho counters PD-related toxicity. Together, these findings indicate that klotho can counteract cognitive deficits related to PD, possibly by modulating α-syn levels, and these findings may be relevant to new therapeutic pathways for PD.

Journal of NeuroscienceVol. 46(18)
University of Minnesota (US), University of California, San Francisco (US), University of California System (US), University Memory and Aging Center (US), Centre for Movement Disorders (CA), Institute on Aging (US), International Neuromodulation Society (US)
American Federation for Aging Research, Glenn Foundation for Medical Research, National Institute of Neurological Disorders and Stroke
Openalex Percentile: Top 36%
Parathyroid Disorders and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.